Related Experiment Video
Updated: Mar 24, 2026

Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection
Published on: September 18, 2020
Functional polymorphisms of macrophage migration inhibitory factor as predictors of morbidity and mortality of
Athina Savva1, Matthijs C Brouwer2, Thierry Roger1
1Infectious Diseases Service, Centre Hospitalier Universitaire Vaudois and University of Lausanne, CH-10111 Lausanne, Switzerland;
Abstract:
Pneumococcal meningitis is the most frequent and critical type of bacterial meningitis. Because cytokines play an important role in the pathogenesis of bacterial meningitis, we examined whether functional polymorphisms of the proinflammatory cytokine macrophage migration inhibitory factor (MIF) were associated with morbidity and mortality of pneumococcal meningitis. Two functional MIF promoter polymorphisms, a microsatellite (-794 CATT5-8; rs5844572) and a single-nucleotide polymorphism (-173 G/C; rs755622) were genotyped in a prospective, nationwide cohort of 405 patients with pneumococcal meningitis and in 329 controls matched for age, gender, and ethnicity. Carriages of the CATT7 and -173 C high-expression MIF alleles were associated with unfavorable outcome (P= 0.005 and 0.003) and death (P= 0.03 and 0.01). In a multivariate logistic regression model, shock [odds ratio (OR) 26.0, P= 0.02] and carriage of the CATT7 allele (OR 5.12,P= 0.04) were the main predictors of mortality. MIF levels in the cerebrospinal fluid were associated with systemic complications and death (P= 0.0002). Streptococcus pneumoniae strongly up-regulated MIF production in whole blood and transcription activity of high-expression MIF promoter Luciferase reporter constructs in THP-1 monocytes. Consistent with these findings, treatment with anti-MIF immunoglogulin G (IgG) antibodies reduced bacterial loads and improved survival in a mouse model of pneumococcal pneumonia and sepsis. The present study provides strong evidence that carriage of high-expression MIF alleles is a genetic marker of morbidity and mortality of pneumococcal meningitis and also suggests a potential role for MIF as a target of immune-modulating adjunctive therapy.
Insights
High-expression alleles of the macrophage migration inhibitory factor (MIF) gene are linked to worse outcomes and death in pneumococcal meningitis. MIF may be a therapeutic target for this critical bacterial infection.
Area of Science:
- Immunogenetics
- Infectious Diseases
- Molecular Biology
Background:
- Pneumococcal meningitis is a severe bacterial infection.
- Cytokines, including macrophage migration inhibitory factor (MIF), are implicated in disease pathogenesis.
- Genetic variations in MIF may influence susceptibility and severity.
Purpose of the Study:
- To investigate the association between functional polymorphisms in the MIF gene and the clinical outcomes of pneumococcal meningitis.
- To explore the role of MIF in the inflammatory response and its potential as a therapeutic target.
Main Methods:
- Genotyping of two functional MIF promoter polymorphisms (-794 CATT5-8 and -173 G/C) in 405 patients and 329 controls.
- Analysis of MIF levels in cerebrospinal fluid.
- In vitro studies on MIF production by Streptococcus pneumoniae.
- Evaluation of anti-MIF antibody treatment in a mouse model.
Main Results:
- Carriage of high-expression MIF alleles (CATT7 and -173 C) was significantly associated with unfavorable outcomes and increased mortality.
- Shock and CATT7 allele carriage were independent predictors of mortality.
- Elevated MIF levels in cerebrospinal fluid correlated with systemic complications and death.
- Streptococcus pneumoniae up-regulated MIF production, and anti-MIF antibodies improved survival in mice.
Conclusions:
- High-expression MIF alleles serve as a genetic marker for pneumococcal meningitis morbidity and mortality.
- MIF plays a critical role in the pathogenesis of pneumococcal meningitis.
- Targeting MIF with immunomodulatory therapy may offer a novel treatment strategy.
